CHIMERIX INC [CMRX] has reported a net loss of $82,095,000,000.0 for year ended Dec 31, 2023.
The Company said in a filing before the Securities and Exchange Commission that its total revenue for the year was $324.0 million
Based in DURHAM, North Carolina, CHIMERIX INC operates in the MANUFACTURING sector.
In the fiscal year ended December 31, 2023, the company reported total revenues of $324 million, a significant increase from the total revenues of $33.824 billion in the previous year ended December 31, 2022. The revenues for the year ended December 31, 2021, were $1.979 billion.
The cost of goods sold for the year ended December 31, 2023, was not applicable (0), compared to $447 million for the year ended December 31, 2022. There were no costs of goods sold reported for the year ended December 31, 2021.
The gross profit for the fiscal year ended December 31, 2023, amounted to $324 million, higher than the gross profit of $33.377 billion in the previous year and $1.979 billion for the year ended December 31, 2021.
Operating expenses, including research and development and general and administrative costs, totaled $93.389 million for the year ended December 31, 2023, compared to $93.763 million in the previous year and $175.379 million in 2021. The loss from operations for the year ended December 31, 2023, was $93.065 million, worse than the loss of $60.386 million in the prior year and $173.4 million in 2021.
Other income, such as interest income and gains on the sale of businesses, amounted to $10.97 million for the year ended December 31, 2023, higher than the $2.919 million reported in the previous year. There were no other income numbers reported for the year ended December 31, 2021.
The net loss for the fiscal year ended December 31, 2023, was $82.095 million, contrasting with the net income of $172.167 million in the previous year and the net loss of $173.236 million in 2021.
Other comprehensive income or loss for the year ended December 31, 2023, was -$81.751 million, compared to $171.851 million in the previous year and -$173.257 million in 2021.
In terms of earnings per share, the company reported a basic net loss per share of ($0.93) for the year ended December 31, 2023, while it reported earnings per share of $1.97 in the previous year and a net loss per share of ($2.04) in 2021. The diluted net loss per share for the year ended December 31, 2023, was also ($0.93), compared to $1.94 in the previous year and ($2.04) in 2021.
Weighted-average shares outstanding slightly increased to 88.604 million shares for both basic and diluted calculations.
In addition, the company reported revenues from contract and grant revenue of $275,000 for the year ended December 31, 2023, compared to $942,000 in the previous year. Licensing revenue and royalty revenue also exhibited fluctuations across the three years as per the given data.
Also Read: